Effect of insulin and feed/fast cycle on vaccine efficacy and safety.

Project Information

IMEIV

Grant agreement ID: 101110724

DOI

10.3030/101110724

Project closed

EC signature date 7 April 2023

Start date 1 October 2023

End date 31 March 2026

Funded under

• Marie Skłodowska-Curie Actions (MSCA)

Total cost

No data

EU contribution

€ 175 920,00

Coordinated by

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (1)

Communication, Dissemination & Exploitation Plan

The plan describes the planned measures to maximize the impact of the project, including the dissemination and exploitation measures that are planned, and the target group(s) addressed. Regarding communication measures and public engagement strategy, the aim is to inform and reach out to society and show the activities performed, and the use and the benefits the project will have for citizens.

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cycle for all data sets that will be collected, processed or generated by the action. It is a document describing what data will be collected, processed or generated and following what methodology and standards, whether and how this data will be shared and/or made open, and how it will be curated and preserved

Publications

Peer reviewed articles (4)

Peptide hormones and bile acids shaping immune tolerance of the liver: implications and applications

Author(s): Gustav van Niekerk, Yana Kumpanenko, Joran Degryse, Johan Fevery, Kai Dallmeier
Published in: Protein & Cell, Issue 17, 2026, ISSN 1674-800X
Publisher: Oxford University Press (OUP)
DOI: 10.1093/PROCEL/PWAF096

Cholecystokinin and gastrin as immune modulating hormones: Implications and applications

Author(s): Gustav van Niekerk, Lara Kelchtermans, Elias Broeckhoven, Lotte Coelmont, Yeranddy A. Alpizar, Kai Dallmeier
Published in: Cytokine & Growth Factor Reviews, Issue 80, 2024, ISSN 1359-6101
Publisher: Elsevier BV
DOI: 10.1016/J.CYTOGFR.2024.11.003

GLP-1R agonist therapy and vaccine response: Neglected implications

Author(s): Gustav van Niekerk, Lotte Coelmont, Yeranddy A. Alpizar, Lara Kelchtermans, Elias Broeckhoven, Kai Dallmeier
Published in: Cytokine & Growth Factor Reviews, Issue 78, 2024, ISSN 1359-6101
Publisher: Elsevier BV
DOI: 10.1016/J.CYTOGFR.2024.07.006

Beyond metabolic benefits: The underexplored immunomodulatory effects of GLP-1/glucagon agonists

Author(s): Gustav van Niekerk, Johan Fevery, Kai Dallmeier
Published in: Journal of Hepatology, Issue 83, 2026, ISSN 0168-8278
Publisher: Elsevier BV
DOI: 10.1016/J.JHEP.2025.02.025